Head and Neck Squamous Cell Carcinoma Clinical Trials

559 clinical trials for Head and Neck Squamous Cell Carcinoma across international registries, including 144 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer — RECRUITING · PHASE1
• PET/CT Follow up for Head and Neck Squamous Cell Carcinoma — RECRUITING · NA
• A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer — RECRUITING · PHASE2
• 3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial — RECRUITING · PHASE2
• Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma — RECRUITING · NA
• Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC — RECRUITING · PHASE2
• A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE2
• A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation — RECRUITING · PHASE1
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors — RECRUITING · PHASE1
• A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors — RECRUITING · PHASE1
• Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer — RECRUITING · PHASE2
• CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs — RECRUITING · PHASE2
• PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC — RECRUITING · PHASE2
• A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of IDP-001 in Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Phase 1 of CTX-8371 in Patients With Advanced Malignancies — RECRUITING · PHASE1
• A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors — RECRUITING · PHASE2
• Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer — RECRUITING · PHASE1
• Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer — RECRUITING · PHASE2
• H101 Plus TACE for r/m HNSCC — RECRUITING · PHASE2
• Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation — RECRUITING · NA
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis — RECRUITING · PHASE1
• A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2) — RECRUITING · PHASE3
• Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery — RECRUITING · PHASE2
• Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE2
• Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE2
• A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. — RECRUITING · PHASE1
• Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis — RECRUITING · PHASE1
• A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC — RECRUITING · PHASE1
• A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors — RECRUITING · PHASE1
• Evaluation of the Validity of Cervical Ultrasonography Compared with Computed Tomography in the Assessment of Cervical Lymph Node Status in Patients with Head and Neck Cancer. — RECRUITING
• Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer — RECRUITING · PHASE2
• Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan — RECRUITING · PHASE1
• Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC — RECRUITING · PHASE2
• A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types — RECRUITING · PHASE1
• A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC) — RECRUITING
• Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study. — RECRUITING · PHASE4
• Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors — RECRUITING · PHASE1
• A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment — RECRUITING · NA
• A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1) — RECRUITING · PHASE3
• Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) — RECRUITING · PHASE1
• A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations — RECRUITING · PHASE1
• A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer — RECRUITING · PHASE2
• High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer — RECRUITING · PHASE3
• Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE1
• (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE1
• Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer — RECRUITING · PHASE2

Refine this search